NDC 53808-0990

TRIZIVIR

Abacavir Sulfate, Lamivudine, And Zidovudine

TRIZIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Abacavir Sulfate; Lamivudine; Zidovudine.

• Product ID: 53808-0990_a6299f1c-1ddb-4da4-a38d-2cb34eca0c02
• NDC: 53808-0990
• Product Type: Human Prescription Drug
• Proprietary Name: TRIZIVIR
• Generic Name: Abacavir Sulfate, Lamivudine, And Zidovudine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2013-02-01
• Marketing Category: NDA / NDA
• Application Number: NDA021205
• Labeler Name: State of Florida DOH Central Pharmacy
• Substance Name: ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
• Active Ingredient Strength: 300 mg/1; mg/1; mg/1
• Pharm Classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 53808-0990-1

30 TABLET, FILM COATED in 1 BLISTER PACK (53808-0990-1)

• Marketing Start Date: 2013-02-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 53808-0990-1 [53808099001]

TRIZIVIR TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA021205
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-02-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
ABACAVIR SULFATE	300 mg/1

OpenFDA Data

• SPL SET ID: 3354e50f-4dc5-413f-b5ae-87353ab8913d
• Manufacturer:
  • State of Florida DOH Central Pharmacy
• UNII:
  • J220T4J9Q2
  • 2T8Q726O95
  • 4B9XT59T7S
• RxNorm Concept Unique ID - RxCUI:
  • 285028
  • 307650

Pharmacological Class

• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC Crossover Matching brand name "TRIZIVIR" or generic name "Abacavir Sulfate, Lamivudine, And Zidovudine"

NDC	Brand Name	Generic Name
49702-217	TRIZIVIR	abacavir sulfate, lamivudine, and zidovudine
53808-0990	TRIZIVIR	abacavir sulfate, lamivudine, and zidovudine